Video Experimental Relacionado

Updated: Jun 26, 2025

Control of Eating Behavior Using a Novel Feedback System
04:48

Control of Eating Behavior Using a Novel Feedback System

Published on: May 8, 2018

11.0K

Un medicamento experimental para la obesidad tiene un doble efecto para reducir el peso

Asher Mullard

    Nature
    |May 15, 2024
    PubMed
    Resumen

    No abstract available in PubMed .

    Palabras clave:
    QuímicaDescubrimiento de drogasObesidad

    Más Videos Relacionados

    Self-Administration of Drugs in Mouse Models of Feeding and Obesity03:37

    Self-Administration of Drugs in Mouse Models of Feeding and Obesity

    Published on: June 8, 2021

    4.5K
    A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats06:28

    A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats

    Published on: April 28, 2023

    827

    Videos de Conceptos Relacionados

    Glucagon-like Receptor Agonists01:24

    Glucagon-like Receptor Agonists

    Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
    GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
    318